Current Status and Future Prospects of TROP-2 ADCs in Lung Cancer Treatment
Mingyi Li,1,* Meng Jin,2,* Hao Peng,3 Haitao Wang,1 Qian Shen,2 Lei Zhang1,4 1Department of Pulmonary and Critical Care Medicine, NHC Key Laboratory of Respiratory Diseases, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, People&...
Saved in:
Main Authors: | Li M (Author), Jin M (Author), Peng H (Author), Wang H (Author), Shen Q (Author), Zhang L (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2024-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Progress and Innovative Combination Therapies in Trop-2-Targeted ADCs
by: Yizhi Jiang, et al.
Published: (2024) -
Impact of Endocytosis Mechanisms for the Receptors Targeted by the Currently Approved Antibody-Drug Conjugates (ADCs)-A Necessity for Future ADC Research and Development
by: Manar Hammood, et al.
Published: (2021) -
Trop2-targeted therapy in breast cancer
by: Yixuan Hu, et al.
Published: (2024) -
NETs and CF Lung Disease: Current Status and Future Prospects
by: Robert D. Gray, et al.
Published: (2015) -
Une femme trop gaie
by: Thierry Savatier
Published: (2003)